Stuart Chaussee & Associates’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30
Closed -$4.13K 134
2025
Q3
$4.13K Hold
30
﹤0.01% 172
2025
Q2
$2.7K Hold
30
﹤0.01% 174
2025
Q1
$2.48K Hold
30
﹤0.01% 180
2024
Q4
$3.78K Hold
30
﹤0.01% 174
2024
Q3
$4.02K Hold
30
﹤0.01% 158
2024
Q2
$4.45K Hold
30
﹤0.01% 154
2024
Q1
$3.38K Hold
30
﹤0.01% 152
2023
Q4
$3.26K Hold
30
﹤0.01% 144
2023
Q3
$3.01K Hold
30
﹤0.01% 126
2023
Q2
$3.34K Hold
30
﹤0.01% 125
2023
Q1
$3.23K Hold
30
﹤0.01% 131
2022
Q4
$2.62K Hold
30
﹤0.01% 144
2022
Q3
$2K Hold
30
﹤0.01% 143
2022
Q2
$3K Hold
30
0.01% 147
2022
Q1
$4K Sell
30
-43
-59% -$5.45K ﹤0.01% 155
2021
Q4
$12K Hold
73
0.01% 112
2021
Q3
$8K Hold
73
0.01% 116
2021
Q2
$10K Hold
73
﹤0.01% 110
2021
Q1
$9K Buy
+73
New +$9.17K ﹤0.01% 131
2020
Q1
Sell
-44
Closed -$3K 122
2019
Q4
$3K Hold
44
﹤0.01% 107
2019
Q3
$3K Hold
44
﹤0.01% 109
2019
Q2
$2K Hold
44
﹤0.01% 123
2019
Q1
$2K Hold
44
﹤0.01% 119
2018
Q4
$1K Hold
44
﹤0.01% 115
2018
Q3
$2K Hold
44
﹤0.01% 126
2018
Q2
$2K Hold
44
﹤0.01% 128
2018
Q1
$2K Hold
44
0.01% 95
2017
Q4
$2K Buy
+44
New +$1.81K ﹤0.01% 105

Other funds holding TER

Stuart Chaussee & Associates's TER Position: Q4 2025 in Review

Stuart Chaussee & Associates sold out of Teradyne (TER) in Q4 2025, closing a stake of 30 shares — an estimated $4.13K sold.

Stuart Chaussee & Associates first reported a position in TER in Q4 2017 and held it in 28 quarters. The position peaked at $12K in Q4 2021. 1,039 funds tracked by Wall St. Rank hold TER as of Q4 2025.

  • Stuart Chaussee & Associates reported no remaining Teradyne position as of Q4 2025 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 30 Teradyne shares in Q4 2025, an estimated $4.13K.
  • Stuart Chaussee & Associates first reported a position in Teradyne in Q4 2017 and held it in 28 quarters.
  • Stuart Chaussee & Associates's Teradyne position peaked at $12K in Q4 2021.
  • 1,039 funds tracked by Wall St. Rank held Teradyne as of Q4 2025.

Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.